Pharmacokinetics of methindion--a new anticonvulsant
Gilev, A.P.; Koptelova, M.N.; Shafro, E.A.
Biulleten' Eksperimental'noi Biologii i Meditsiny 78(10): 59-61
1974
ISSN/ISBN: 0365-9615 PMID: 4461122 Document Number: 77864
Document emailed within 1 workday
Related Documents
Rylance, G. 1984: Pharmacokinetics of anticonvulsant drugs and their dosage in childhood epilepsy Recenti Progressi in Medicina 75(1): 51-65Martin, S.W.; Bishop, F.E.; Kerr, B.M.; Moor, M.; Moore, M.; Sheffels, P.; Rashed, M.; Slatter, J.G.; Berthon-Cédille, L.; Lepage, F.; Descombe, J.J.; Picard, M.; Baillie, T.A.; Levy, R.H. 1997: Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(1): 40-46
Christiansen, C.; Rødbro, P. 1979: Anticonvulsant-induced osteomalacia. Vitamin D metabolism disorders in epileptics on anticonvulsant therapy Ugeskrift for Laeger 141(5): 280-284
Graziani, G.; Tirone, F.; Barbadoro, E.; Testa, R. 1983: Denzimol, a new anticonvulsant drug. I. General anticonvulsant profile Arzneimittel-Forschung 33(8): 1155-1160
Frey, O.R. 2001: Anticonvulsant weaning? how should anticonvulsant therapy be discontinued? Medizinische Monatsschrift für Pharmazeuten 24(8): 266
Paxton, J.W. 1981: Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics New Zealand Medical Journal 94(697): 423-425
Brion, N.; Contrepois, A.; Carbon, C. 1983: From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding Presse Medicale 12(5): 293-296
Daniel, W.; Syrek, M.; Janczar, L.; Boksa, J. 1995: The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine Polish Journal of Pharmacology 47(2): 127-136
De Mey, C.; Scharpe, S.; De Bock, R.; Bossaert, L. 1981: Predictive pharmacokinetics of amikacin using actually measured and assumed parameters, applied in 1-compartment linear pharmacokinetics Archives Internationales de Pharmacodynamie et de Therapie 253(2): 323-324
Yamamoto, N.; Yanagi, K.; Matuyama, H.; Shimizu, K.; Mitsui, H.; Shimabukuro, T.; Yamamoto, M.; Sakatoku, J.; Fujita, T.; Matsuoka, K. 1987: Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule) Hinyokika Kiyo. Acta Urologica Japonica 33(11): 1760-1765
Chemburkar, J.A.; Ravindranath, S.; Desai, A.D. 1973: Diazepam as an anticonvulsant Neurology India 21(3): 124-127
Adair, I.V. 1975: Anticonvulsant osteomalacia Journal of the Royal College of Surgeons of Edinburgh 20(6): 380-383
Post, R.M. 1990: ECT: the anticonvulsant connection Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 3(2): 89-92; Discussion: 97-99
Turkanis, S.A.; Cely, W.; Olsen, D.M.; Karler, R. 1974: Anticonvulsant properties of cannabidiol Research Communications in Chemical Pathology and Pharmacology 8(2): 231-246
Bathla, S.; Suneja, A.; Guleria, K.; Agarwal, N. 2002: Dilantin as anticonvulsant in eclampsia Journal of the Indian Medical Association 100(9): 561-564
Morris, H.H. 1979: Lidocaine: a neglected anticonvulsant? Southern Medical Journal 72(12): 1564-1566
Lander, C.M.; Livingstone, I.; Tyrer, J.H.; Eadie, M.J. 1981: The clearance of anticonvulsant drugs in pregnancy Clinical and Experimental Neurology 17: 71-78
Holland, K.D.; Naritoku, D.K.; McKeon, A.C.; Ferrendelli, J.A.; Covey, D.F. 1990: Convulsant and anticonvulsant cyclopentanones and cyclohexanones Molecular Pharmacology 37(1): 98-103
Tyrer, J.H.; Eadie, M.J.; Sutherland, J.M. 1970: Investigation of an outbreak of anticonvulsant intoxication Proceedings of the Australian Association of Neurologists 7: 15-18
Matarazzo, E.B. 1976: Side effects of anticonvulsant drugs Amb: Revista da Associacao Medica Brasileira 22(4): 139-142